Drupal.behaviors.print = function(context) {window.print();window.close();}>
Invivoscribe Licenses Patent from Takara for FLT3-ITD Mutation Detection
December 05, 2012
Invivoscribe Licenses Patent from Takara for FLT3-ITD Mutation Detection
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Invivoscribe Claims Win in FLT3 Patent Case
May 14, 2013 / GenomeWeb Daily News
Trovagene, PerkinElmer Ink Assay Development Deal Targeting Liver Cancer
April 26, 2013 / GenomeWeb Daily News
Cepheid, OHSU Co-developing Cancer MDx Tests for GeneXpert
February 19, 2013 / GenomeWeb Daily News
Qiagen Expands Companion Dx Portfolio with Three Licensing Deals; Exceeds 2012 QiaSymphony Placement Target
January 7, 2013 / GenomeWeb Daily News
Seegene, DuPont Ink MDx Tech Licensing Deal
December 10, 2012 / GenomeWeb Daily News